Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cognitive impairment in neuro-Behcet's disease and multiple sclerosis: a comparative study.
Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis.
The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.
Efficacy and safety of Alemtuzumab in treatment-naive patients with relapsing-remitting multiple sclerosis: Four-year follow-up of the Care-MS I study.
Biomarkers in multiple sclerosis.
FDA approves injectable drug to treat opioid-dependent patients
Demyelinating Diseases: Myeloperoxidase as an Imaging Biomarker and Therapeutic Target.
Functional assessment of magno, parvo and konio-cellular pathways; current state and future clinical applications.
Catheter venography and endovascular treatment of chronic cerebrospinal venous insufficiency.
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study.
Abstracts of ECTRIMS (Congress of the European Committee for Treatment and Research in Multiple Sclerosis) 2013. October 2-5, 2013. Copenhagen, Denmark.
Endocannabinoids and neurodegenerative diseases.
Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Dimethyl fumarate (Tecfidera) for multiple sclerosis.
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
The prospects of minocycline in multiple sclerosis.
T cell vaccination in multiple sclerosis: results of a preliminary study.
Long-term TENS treatment decreases cortical motor representation in multiple sclerosis.
Reductions in neuronal peroxisomes in multiple sclerosis grey matter.
A new cognitive rehabilitation programme for patients with multiple sclerosis: the 'MS-line! Project'
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.
Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis.
Intractable Nausea and Vomiting from Autoantibodies Against a Brain Water Channel.
Neuromuscular taping in multiple sclerosis. A pilot study.
FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ(42))-Induced Impairment of Spatial Learning and Memory in Rats.
Pages
« first
‹ previous
…
182
183
184
185
186
187
188
189
190
…
next ›
last »